Ceftazidime Olikla 1g
powder for solution for injection/infusion 10 vials
Ceftazidime Olikla 1g
powder for solution for injection/infusion 10 vials
|
Registered name:
Ceftazidime Olikla |
|
| Registration number | 15/300/22-C |
| SUKL code | 0279311 |
| Date of first registration / renewal | 14.5.2024 |
| Marketing authorisation holder | Olikla s.r.o., Náměstí Smiřických 42, 281 63 Kostelec nad Černými lesy, Czech Republic |
| Producer | Kymos S.L., Ronda de Can Fatjó, 7B (Parque Tecnológico del Vallés), Cerdanyola del Vallés, 08290 Barcelona, Spain |
| Producer | Eurofins Analytical Services Hungary Kft., Anonymus u. 6, 1045 Budapešť, Hungary |
-
Active substance
Each vial contains ceftazidime 1g (as pentahydrate).
-
Excipients with known effect
Sodium carbonate (anhydrous sterile). Each gram of ceftazidime contains approximately 52mg (2.3mmol) of sodium.
-
Therapeutic area
Antibiotics -
Pharmacotherapeutic group
Antibacterials for systemic use. Third-generation cephalosporins. -
ATC group
J01DD02 -
Dosage form
Powder for solution for injection or infusion (Powder for injection or infusion).
-
Route of administration
Intramucsular or intravenous administration -
Storage conditions
Store in the original package in order to protect from light. -
Expiration
2 years -
Reimbursement from health insurance companies
Prescription only medicine. Unpaid -
Current availability in the Czech market and delivery time
No -
EAN
8594184140567 -
PDK code
5224317
Our Products
Dear Madam, Dear Sir,
Please note that the Olikla website you are accessing is not intended for the general public because it contains expert information on drugs and medical devices, including advertising messages, relating to drugs and medical devices. These messages and information are solely for professionals under Section 2a of Act No. 40/1995 Coll., on Regulation of Advertising, as amended, i.e. persons authorised to prescribe or dispense drugs or medical devices (“professionals”).
Please note that if you are not a professional, you risk endangering your health or the health of others if you misunderstand or misinterpret the information obtained, in particular the advertising messages which may be part of this website, or use it for self-diagnosis or the determination of medical treatment, whether in relation to you personally or in relation to others.
I declare that I have acquainted myself with the above advice, including the definition of a professional, and I am aware of the risks a person other than a professional accessing this website is exposed to.
Our Products
Dear Madam, Dear Sir,
In the previous step, you confirmed you are a professional as defined by Act No. 40/1995 Coll., on Regulation of Advertising, as amended, i.e. that you are a person authorised to prescribe or dispense drugs and medical devices. If your declaration is untrue, please note that you are endangering your health or the health of others.
YES, I declare I am a professional under Section 2a of Act No. 40/1995 Coll., on Regulation of Advertising.
NO, I am not a professional under Section 2a of Act No. 40/1995 Coll., on Regulation of Advertising.